1. Federal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russia; Moscow Institute of Physics and Technology, Dolgoprudniy, Russia 2. Federal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russia 3. Moscow Institute of Physics and Technology, Dolgoprudniy, Russia 4. Department of Urology, Moscow State Medical Stomatological University, Moscow, Russia
The RNA-seq approach for prostate cancer candidate RNA biomarkers screening in plasma and urine obtained by minimally invasive or noninvasive methods is proved to be feasible. Significant amount of RNA biomarkers associated with prostate cancer according to the literature were found in plasma and urine samples obtained from patients with benign prostatic hyperplasia (BPH). The number of detected markers was shown to vary in accordance with method of library preparation used for transcriptome profiling. The detection of known RNA biomarkers for prostate cancer in urine and plasma samples shows the feasibility of such method for minimally invasive diagnostics. The fact of presence of the same RNA biomarkers in samples from patients with BPH suggests their possible lack of specificity and confirms the need for further research in this area.
Nikitina A.S. et al. Primary candidate RNA biomarker screening by RNA-seq for prostate cancer diagnostics // Biomeditsinskaya Khimiya. - 2015. - V. 61. -N 6. - P. 781-784.
Nikitina A.S. et al., "Primary candidate RNA biomarker screening by RNA-seq for prostate cancer diagnostics." Biomeditsinskaya Khimiya 61.6 (2015): 781-784.
Nikitina, A. S., Babenko, V. V., Babalyan, K. A., Vasiliev, A. O., Govorov, A. V., Prilepskaya, E. A., Danilenko, S. A., Selezneva, O. V., Sharova, E. I. (2015). Primary candidate RNA biomarker screening by RNA-seq for prostate cancer diagnostics. Biomeditsinskaya Khimiya, 61(6), 781-784.
Thompson I.M., Pauler D.K., Goodman P.J., Tangen C.M., Lucia M.S., Parneset H.L. Minasian L.M., Ford L.G., Lippman S.M., Crawford E.D., Crowley J.J., Coltman C.A. (2004) N. Engl. J. Med., 350, 2239-2246. CrossRef Scholar google search
Hessels D., van Gils M.P., van Hooij O., Jannink S.A., Witjes J.A., Verhaegh G.W., Schalken J.A. (2010) Prostate, 70, 10-16. CrossRef Scholar google search
Catalona W., Partin A., Sanda M., Wei J., Klee G., Bangma C., Slawin K.M., Marks L.S., Loeb S., Broyles D.L. et al. (2011) J. Urol., 185, 1650-1655. CrossRef Scholar google search
Ross-Adams H., Lamba A.D., Dunninga M.J., Halima S., Lindbergd J., Massie C.M., Egevad L.A., Russell R., Ramos-Montoya A., Vowler S.L. et al. (2015) EBioMedicine, 2, 1133-1144. CrossRef Scholar google search
Tomlins S.A., Alshalalfa M., Davicioni E., Erho N., Yousefi K., Zhao S., Haddad Z., Den R.B., Dicker A.P., Trock B.J. et al. (2015) Eur. Urol., 68, 555-567. CrossRef Scholar google search
Trapnell C., Roberts A., Goff L., Pertea G., Kim D., Kelley D.R., Pimentel H., Salzberg S.L., Rinn J.L., Pachter L. (2014) Nat. Protoc., 7, 562-578. CrossRef Scholar google search
Ren S.1., Wang F., Shen J., Sun Y., Xu W., Lu J., Wei M., Xu C., Wu C., Zhang Z. et al. (2013) Eur. J. Cancer., 49, 2949-2959. CrossRef Scholar google search
You J., Cozzi P., Walsh B., Willcox M., Kearsley J., Russell P., Li Y. (2010) Crit. Rev. Oncol. Hematol., 73, 10-22. CrossRef Scholar google search
Rönnau C.G.H., Verhaegh G.W., Luna-Velez M.V., Schalken J.A. (2014) BioMed. Research International, 591703. Scholar google search
Mottet N., Bellmunt J., Briers E., van den Bergh R.C.N., Bolla M., van Casteren N.J. (2015) Guidlines on prostate cancer, European Association of Urology, p. 22. Scholar google search
